SEMA3C and posterior cortical atrophy: As shown in Fig 1A and B, increased SEMA3C expression was associated with advanced PCa that have been heavily treated with NHT and docetaxel (DTXL) (*P = 0.02), and CRPC bone metastases (**P = 0.0075; Fig 1B).